These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 24778662

  • 1. The effects of intradermal botulinum toxin type a injections on pain symptoms of patients with diabetic neuropathy.
    Ghasemi M, Ansari M, Basiri K, Shaigannejad V.
    J Res Med Sci; 2014 Feb; 19(2):106-11. PubMed ID: 24778662
    [Abstract] [Full Text] [Related]

  • 2. The Effect of Intradermal Botulinum Toxin a injections on painful diabetic polyneuropathy.
    Taheri M, Sedaghat M, Solhpour A, Rostami P, Safarpour Lima B.
    Diabetes Metab Syndr; 2020 Feb; 14(6):1823-1828. PubMed ID: 32961514
    [Abstract] [Full Text] [Related]

  • 3. The effects of botulinum toxin type A injection on pain symptoms, quality of life, and sleep quality of patients with diabetic neuropathy: A randomized double-blind clinical trial.
    Salehi H, Moussaei M, Kamiab Z, Vakilian A.
    Iran J Neurol; 2019 Jul 06; 18(3):99-107. PubMed ID: 31749930
    [Abstract] [Full Text] [Related]

  • 4. The Efficacy of Intradermal Injection of Botulinum Toxin Type-A on Painful Diabetic Neuropathy: A Systematic Review.
    Bayat M, Raeissadat SA, Hojjati F, Faghani P, Naseri N, Ghafari V.
    Anesth Pain Med; 2023 Oct 06; 13(5):e136260. PubMed ID: 38476988
    [Abstract] [Full Text] [Related]

  • 5. Botulinum Toxin Type A for Diabetic Peripheral Neuropathy Pain: A Systematic Review and Meta-Analysis.
    Wang C, Zhang Q, Wang R, Xu L.
    J Pain Res; 2021 Oct 06; 14():3855-3863. PubMed ID: 34938114
    [Abstract] [Full Text] [Related]

  • 6. [Botulinum toxin and painful peripheral neuropathies: what should be expected?].
    Ranoux D.
    Rev Neurol (Paris); 2011 Jan 06; 167(1):46-50. PubMed ID: 21194720
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.
    Yuan RY, Sheu JJ, Yu JM, Chen WT, Tseng IJ, Chang HH, Hu CJ.
    Neurology; 2009 Apr 28; 72(17):1473-8. PubMed ID: 19246421
    [Abstract] [Full Text] [Related]

  • 8. Botulinum Toxin-A for Painful Diabetic Neuropathy: A Meta-Analysis.
    Lakhan SE, Velasco DN, Tepper D.
    Pain Med; 2015 Sep 28; 16(9):1773-80. PubMed ID: 25800040
    [Abstract] [Full Text] [Related]

  • 9. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
    Ranoux D, Attal N, Morain F, Bouhassira D.
    Ann Neurol; 2008 Sep 28; 64(3):274-83. PubMed ID: 18546285
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of perineural hypertonic saline injection versus acupoints of foot in the management of diabetic neuropathy: a multicenter, double-blinded randomized controlled trial.
    Heidari N, Ashraf A, Mohamadi Jahromi LS, Parvin R.
    Pain Manag; 2023 Jan 28; 13(1):35-43. PubMed ID: 36384321
    [Abstract] [Full Text] [Related]

  • 11. Painful Diabetic Peripheral Neuropathy Study of Chinese Outpatients (PDNSCOPE): A Multicentre Cross-Sectional Registry Study of Clinical Characteristics and Treatment in Mainland China.
    Zhang Y, Zhang S, Pan L, Wang B, Sun Y, Gao L, Wang L, Cui L, Zhang Q, Shang H, Jin S, Qin X, Geng D, Yu X, Yang L, Li L, Li Z, Yan C, Sun H, Sun T, Du B, Cao J, Hu F, Ma J, Zhou S, Zhao F, Li W, Zheng J, Yi Y, Xu J, Hu B, Sheng B, Li Z, Zhao Z, Yang T, Wang N, Zhao H, Mima D, Qu H, Wang Y, Song F, Li X, Li N, Fan D.
    Pain Ther; 2021 Dec 28; 10(2):1355-1373. PubMed ID: 34363598
    [Abstract] [Full Text] [Related]

  • 12. Acupuncture in diabetic peripheral neuropathy-protocol for the randomized, multicenter ACUDPN trial.
    Dietzel J, Hörder S, Habermann IV, Meyer-Hamme G, Hahn K, Ortiz M, Roll S, Linde K, Irnich D, Hammes M, Nögel R, Wullinger M, Wortman V, Hummelsberger J, Willich SN, Schröder S, Brinkhaus B.
    Trials; 2021 Feb 26; 22(1):164. PubMed ID: 33637134
    [Abstract] [Full Text] [Related]

  • 13. Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial.
    Zhang H, Lian Y, Ma Y, Chen Y, He C, Xie N, Wu C.
    J Headache Pain; 2014 Sep 27; 15(1):65. PubMed ID: 25263254
    [Abstract] [Full Text] [Related]

  • 14. Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection.
    Bach-Rojecky L, Salković-Petrisić M, Lacković Z.
    Eur J Pharmacol; 2010 May 10; 633(1-3):10-4. PubMed ID: 20123097
    [Abstract] [Full Text] [Related]

  • 15. Botulinum toxin type A for neuropathic pain in patients with spinal cord injury.
    Han ZA, Song DH, Oh HM, Chung ME.
    Ann Neurol; 2016 Apr 10; 79(4):569-78. PubMed ID: 26814620
    [Abstract] [Full Text] [Related]

  • 16. A preliminary study of painless and effective transdermal botulinum toxin A delivery by jet nebulization for treatment of primary hyperhidrosis.
    Iannitti T, Palmieri B, Aspiro A, Di Cerbo A.
    Drug Des Devel Ther; 2014 Apr 10; 8():931-5. PubMed ID: 25075176
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.
    Vinik AI, Bril V, Kempler P, Litchy WJ, Tesfaye S, Price KL, Bastyr EJ, MBBQ Study Group.
    Clin Ther; 2005 Aug 10; 27(8):1164-80. PubMed ID: 16199243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.